CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE
Clinical trials for CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CML drug combo strategy aims for deeper remission without lifelong side effects
Disease control Recruiting nowThis study tests a new drug, asciminib, as the first treatment for adults newly diagnosed with chronic myeloid leukemia (CML). If the drug alone does not achieve a deep response within 2 to 3 years, a low dose of another targeted therapy is added. The goal is to see if this appro…
Matched conditions: CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Leukemia patients who failed stopping meds may get another shot at drug-free remission
Disease control Recruiting nowThis study tests whether adding asciminib to standard tyrosine kinase inhibitors (TKIs) can help people with chronic myeloid leukemia (CML) safely stop all medication and remain in remission. It includes 69 adults who have been on TKIs for at least 5 years but previously failed t…
Matched conditions: CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE
Phase: PHASE2 • Sponsor: Korean Society of Hematology • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New daily pill shows promise for Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a new daily pill called TERN-701 for adults with chronic myeloid leukemia (CML) who have not responded well to other treatments. The trial has two parts: first, finding the safest dose, then testing that dose in more people. About 180 participants will take the p…
Matched conditions: CHRONIC MYELOID LEUKEMIA, CHRONIC PHASE
Phase: PHASE1, PHASE2 • Sponsor: Terns, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC